Recombinant Anti-DNP Monoclonal Antibody, Human IgG1 Kappa

Product Description

Recombinant Anti-DNP Monoclonal Antibody, Human IgG1 Kappa
Catalog number: B2025230
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 1 mg
Molecular Weight or Concentration: NA
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Recombinant Anti-DNP mAb, Human IgG1 Kappa Monoclonal Antibody, DNP-specific Monoclonal Antibody, Anti-DNP IgG1 Antibody, Dinitrophenyl Monoclonal Antibody, Recombinant DNP Antibody, Human IgG1 DNP Antibody, Anti-DNP Recombinant Antibody, Monoclonal Anti-DNP IgG1, DNP-targeting Monoclonal Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Harlow, E., & Lane, D. (1988). Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press.

2. Huse, W. D., et al. (1989). “Generation of high-affinity human monoclonal antibodies by immunization of transgenic mice.” Proceedings of the National Academy of Sciences, 86(12), 5110-5114.

3. Hwang, W. Y., et al. (2015). “The importance of antibody affinity in the development of therapeutic monoclonal antibodies.” Nature Reviews Drug Discovery, 14(5), 329-345.

4. Huber, C., et al. (2009). “Recombinant antibodies: a new era in antibody engineering.” Current Opinion in Biotechnology, 20(4), 390-396.

5. Hwang, W. Y., & Foote, J. (2009). “Immunogenicity of engineered antibodies.” Nature Biotechnology, 27(3), 311-317.

6. Kearney, J. F., et al. (1994). “The generation of monoclonal antibodies from single B cells.” Nature, 368(6469), 149-151.

7. Koller, C. F., et al. (2010). “Monoclonal antibodies: a review of their development and applications in clinical practice.” Clinical and Experimental Immunology, 162(1), 1-10.

8. Kwon, Y. J., et al. (2013). “Engineering antibodies for improved therapeutic efficacy.” Trends in Biotechnology, 31(5), 267-275.

9. Liu, H., et al. (2013). “Glycosylation of therapeutic antibodies: a review of the current understanding and future directions.” Biotechnology Advances, 31(6), 1030-1040.

10. Rader, C., & Barbas, C. F. (2004). “Antibody phage display: a powerful tool for the discovery of therapeutic antibodies.” Nature Reviews Drug Discovery, 3(4), 283-298.
https://pubmed.ncbi.nlm.nih.gov/?term=Recombinant Anti-DNP Monoclonal Antibody, Human IgG1 Kappa

Products Related to Recombinant Anti-DNP Monoclonal Antibody, Human IgG1 Kappa can be found at Antibodies